000 01488 a2200421 4500
005 20250517025758.0
264 0 _c20160210
008 201602s 0 0 eng d
022 _a1521-4184
024 7 _a10.1002/ardp.201400427
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeller, Max
245 0 0 _aToward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304.
_h[electronic resource]
260 _bArchiv der Pharmazie
_cJun 2015
300 _a390-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aArginine
_xanalogs & derivatives
650 0 4 _aBinding Sites
650 0 4 _aBinding, Competitive
650 0 4 _aCHO Cells
650 0 4 _aCricetulus
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Design
650 0 4 _aLigands
650 0 4 _aMolecular Structure
650 0 4 _aPropionates
_xchemical synthesis
650 0 4 _aProtein Binding
650 0 4 _aRadioligand Assay
650 0 4 _aReceptors, Neuropeptide Y
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTransfection
700 1 _aSchindler, Lisa
700 1 _aBernhardt, Günther
700 1 _aBuschauer, Armin
773 0 _tArchiv der Pharmazie
_gvol. 348
_gno. 6
_gp. 390-8
856 4 0 _uhttps://doi.org/10.1002/ardp.201400427
_zAvailable from publisher's website
999 _c24815175
_d24815175